Delivery Order SPE2DB20D1109-SPE2DB23FP38P
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ultane 250 ML pen bottles. The fixed-price delivery order, valued at $1,641.50, was issued under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.30 Delivery Order contract is for the supply of 4566733376 - ULTANE 250 ML PEN BOTTLE 250ML. The contract is a Firm Fixed Price agreement with a completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of a pharmaceutical product, ULTANE 250 ML PEN BOTTLE 250ML, to the Defense Logistics Agency (DLA), a defense agency. The $1,667.16 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award is for the delivery of pharmaceutical products, including Ultane 250 ML Pen Bottles, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,242.24, is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract, valued at $1,342.99, is a firm fixed price delivery order with a period of performance through March 28, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate indefinite delivery contract (IDC) with DLA,...
- This is a delivery order (SPE2DB20D3101|SPE2DB24FRTZ7) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,162.28 firm fixed-price contract is for the delivery of 4565699989 ULTANE 250 ML PEN BOTTLE 250ML medical supplies. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,285.60 firm fixed price delivery order is for the supply of 4565573981 - ULTANE LIQ 250ML 1S pharmaceutical products. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. government, with significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a competitive delivery order valued at $1,155.12 by the Defense Logistics Agency (DLA) for Ultane 250 ml in pen bottle format. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and was competitively awarded without a set-aside designation. This award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,706.01 firm fixed-price delivery order is for the supply of Ultane Liquid, a 250 mL medication. The contract has a performance period through May 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP38PDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,099.98 firm-fixed-price delivery order is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, with a completion date of June 26, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a smaller $750,000.00 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/23/23 |